Exploring Group A Streptococcus Infections in Infants: A Comprehensive Analysis of Detection, Genotyping, and Antibiotic Resistance Trends in Baghdad
Mengeksplorasi Infeksi Streptokokus Grup A pada Bayi: Analisis Komprehensif tentang Deteksi, Genotipe, dan Tren Resistensi Antibiotik di Baghdad
DOI:
https://doi.org/10.21070/ijhsm.v2i2.124Keywords:
Group A Streptococcus, antibiotic resistance, genotyping, pediatric infections, public health interventionsAbstract
This study aimed to investigate the prevalence, genetic diversity, and antibiotic resistance of Group A Streptococcus (GAS) infections among pediatric populations in Baghdad, addressing the critical public health challenge posed by rising antibiotic resistance and limited surveillance. GAS infections, caused by Streptococcus pyogenes , range from mild pharyngitis to severe invasive diseases like necrotizing fasciitis. The study analyzed 226 pharyngeal swab samples from children aged 3–14, identifying 21 confirmed GAS isolates. Genotyping revealed significant genetic diversity, with prevalent emm types including emm-1, emm-4, and emm-12, alongside virulence genes such as speB and speA . Household contact with infected individuals significantly increased infection risk (p<0.01), emphasizing transmission dynamics. Antibiotic susceptibility testing highlighted alarming resistance levels, particularly to penicillin (29%) and amoxicillin (6%), contrasting with global trends where penicillin resistance remains low. However, azithromycin (93%) and cefuroxime (90%) demonstrated high efficacy, while macrolide resistance, such as erythromycin (45%), is rising. Linezolid maintained 80% susceptibility, crucial for treating multidrug-resistant infections. Clinical manifestations included fever, respiratory disorders, and hemodynamic instability, consistent with invasive GAS disease.
Highlights:
- GAS prevalent with diverse emm types, virulence genes detected.
- High resistance to penicillin; azithromycin, cefuroxime effective.
- Infection risk higher with household exposure; severe symptoms observed.
Keywords: Group A Streptococcus, antibiotic resistance, genotyping, pediatric infections, public health interventions
References
[1]. A.-M. Rick, H. A. Zaheer, and J. M. Martin, “Clinical Features of Group A Streptococcus in Children With Pharyngitis: Carriers Versus Acute Infection,” The Pediatric Infectious Disease Journal, vol. 39, no. 6, pp. 483–488, 2020.
[2]. J. Oliver et al., “Group A Streptococcus Pharyngitis and Pharyngeal Carriage: A Meta-Analysis,” PLOS Neglected Tropical Diseases, vol. 12, no. 3, p. e0006335, 2018.
[3]. H. T. Dong et al., “From the Basics to Emerging Diagnostic Technologies: What Is on the Horizon for Tilapia Disease Diagnostics?,” Reviews in Aquaculture, vol. 15, pp. 186–212, 2023.
[4]. H.-J. Wu, A. H. J. Wang, and M. P. Jennings, “Discovery of Virulence Factors of Pathogenic Bacteria,” Current Opinion in Chemical Biology, vol. 12, no. 1, pp. 93–101, 2008.
[5]. S. S. Khazaal, S. K. Al-Alak, and M. H. Z. Talha, “Molecular Identification of Prevalent Streptococcus Pyogenes Serogroup Associated With Respiratory Tract Infections in Children,” Al-Mustansiriyah Journal of Science, vol. 33, no. 5, pp. 8–16, 2022.
[6]. A. F. Johnson and C. N. LaRock, “Antibiotic Treatment, Mechanisms for Failure, and Adjunctive Therapies for Infections by Group A Streptococcus,” Frontiers in Microbiology, vol. 12, p. 760255, 2021.
[7]. M. K. Ali and F. R. Wadi, “Prevalence of Asymptomatic Streptococcus Pyogenes Carriage and Antibiotic Susceptibility Among Schoolchildren in Baghdad, Iraq,” International Journal of Design & Nature and Ecodynamics, vol. 20, no. 1, pp. 211–216, 2025.
[8]. J. Vakkila et al., “Detection of Group A Streptococcus From Pharyngeal Swab Samples by Bacterial Culture Is Challenged by a Novel MariPOC Point-of-Care Test,” Journal of Clinical Microbiology, vol. 53, no. 7, pp. 2079–2083, 2015.
[9]. J. Oliver et al., “Group A Streptococcus Pharyngitis and Pharyngeal Carriage: A Meta-Analysis,” PLOS Neglected Tropical Diseases, vol. 12, no. 3, p. e0006335, 2018.
[10]. C. R. Mahon and D. C. Lehman, Textbook of Diagnostic Microbiology, 6th ed. St. Louis, MO: Elsevier Health Sciences, 2022.
[11]. J. Hudzicki, “Kirby-Bauer Disk Diffusion Susceptibility Test Protocol,” American Society for Microbiology, vol. 15, no. 1, pp. 1–23, 2009.
[12]. P.-R. Hsueh et al., “Consensus Statement on the Adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-Update) for Enterobacteriaceae in Clinical Microbiology Laboratories in Taiwan,” Journal of Microbiology, Immunology and Infection, vol. 43, no. 5, pp. 452–455, 2010.
[13]. Z. A. Khan, M. F. Siddiqui, and S. Park, “Current and Emerging Methods of Antibiotic Susceptibility Testing,” Diagnostics, vol. 9, no. 2, p. 49, 2019.
[14]. K. Syal et al., “Current and Emerging Techniques for Antibiotic Susceptibility Tests,” Theranostics, vol. 7, no. 7, pp. 1795–1805, 2017.
[15]. Y.-Y. Chuang, Y.-C. Huang, and T.-Y. Lin, “Toxic Shock Syndrome in Children: Epidemiology, Pathogenesis, and Management,” Pediatric Drugs, vol. 7, pp. 11–24, 2005.
[16]. S. Brouwer et al., “Pathogenesis, Epidemiology and Control of Group A Streptococcus Infection,” Nature Reviews Microbiology, vol. 21, no. 7, pp. 431–447, 2023.
[17]. A. Efstratiou and T. Lamagni, “Epidemiology of Streptococcus Pyogenes,” in Streptococcus Pyogenes: Basic Biology to Clinical Manifestations, 2nd ed. 2022. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK343616/
[18]. I. N. Grivea et al., “Emm Types and Clusters and Macrolide Resistance of Pediatric Group A Streptococcal Isolates in Central Greece During 2011–2017,” PLOS ONE, vol. 15, no. 5, p. e0232777, 2020.
[19]. S. Brouwer et al., “Pathogenesis, Epidemiology and Control of Group A Streptococcus Infection,” Nature Reviews Microbiology, vol. 21, no. 7, pp. 431–447, 2023.
[20]. R. Wesgate et al., “Understanding the Risk of Emerging Bacterial Resistance to Over-the-Counter Antibiotics in Topical Sore Throat Medicines,” Journal of Applied Microbiology, vol. 129, no. 4, pp. 916–925, 2020.
[21]. A. Robertson, Understanding the Risk of Emerging Bacterial Resistance From the Use of Sore Throat Over-the-Counter Topical Antibiotics, MSc Thesis, Cardiff University, 2023.
[22]. M. Terreni, M. Taccani, and M. Pregnolato, “New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives,” Molecules, vol. 26, no. 9, p. 2671, 2021.
[23]. S. S. Y. Chang et al., “Predictors of Serious Bacterial Infections Using Serum Biomarkers in an Infant Population Aged 0 to 90 Days: A Prospective Cohort Study,” BMJ Paediatrics Open, vol. 5, no. 1, p. e000861, 2021.
